Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Mario Levis"'
Autor:
Irene Dogliotti, Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Silvio Mercadante, Simone Ragaini, Barbara Botto, Mario Levis, Mattia Novo, Marco Ghislieri, Luca Molinaro, Umberto Mortara, Chiara Consoli, Alessio Lonardo, Giulia Bondielli, Simone Ferrero, Roberto Freilone, Umberto Ricardi, Benedetto Bruno, Federica Cavallo
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Relapse and refractory (R/R) rates after first‐line R‐CHOP in diffuse large B cell lymphomas (DLBCL) are ~40% and ~15% respectively. Aims We conducted a retrospective real‐world analysis aimed at evaluating clinical outcomes
Externí odkaz:
https://doaj.org/article/1d7d6e20f9ba4f66901f58389b759e04
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/a6441addf55c4e1f854253f24c1e0224
Autor:
Anna Di Russo, Gabriele Simontacchi, Andrea Emanuele Guerini, Andrea Riccardo Filippi, Mario Levis, Patrizia Ciammella, Vitaliana De Sanctis, Stefano Vagge, Sofia Meregalli, Giuseppina De Marco, Biancaluisa Lanfranchi, Luigi Spiazzi, Michela Buglione
Publikováno v:
Hemato, Vol 2, Iss 3, Pp 496-504 (2021)
Background: Multiple methods have been implemented to limit the impact of radiotherapy on patients affected by mediastinal lymphoma, including breathing control techniques, image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT),
Externí odkaz:
https://doaj.org/article/c38b372ec20541439afd3acc736a7284
Autor:
Mario Levis, Veronica Dusi, Massimo Magnano, Marzia Cerrato, Elena Gallio, Alessandro Depaoli, Federico Ferraris, Gaetano Maria De Ferrari, Umberto Ricardi, Matteo Anselmino
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionCatheter ablation (CA) is the current standard of care for patients suffering drug-refractory monomorphic ventricular tachycardias (MMVTs). Yet, despite significant technological improvements, recurrences remain common, leading to increas
Externí odkaz:
https://doaj.org/article/99efe4d07d0342d6a89d8c42721112c4
Autor:
Melissa Thomas, Gilles Defraene, Mario Levis, Edmond Sterpin, Maarten Lambrecht, Umberto Ricardi, Karin Haustermans
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 16, Iss , Pp 50-53 (2020)
While proton therapy offers an excellent dose conformity and sparing of organs at risk, this can be compromised by uncertainties, e.g. organ motion. This study aimed to investigate the influence of cardiac motion on the contoured oesophagus using ele
Externí odkaz:
https://doaj.org/article/e04df4da7e2b40bdaee148ee90f30a48
Autor:
Andrea Riccardo Filippi, Sofia Meregalli, Anna DI Russo, Mario Levis, Patrizia Ciammella, Michela Buglione, Andrea Emanuele Guerini, Giuseppina De Marco, Vitaliana De Sanctis, Stefano Vagge, Umberto Ricardi, Gabriele Simontacchi, on behalf of the Fondazione Italiana Linfomi (FIL) Radiotherapy Committee
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-16 (2020)
Abstract Aim Advances in therapy have resulted in improved cure rates and an increasing number of long-term Hodgkin's lymphoma (HL) survivors. However, radiotherapy (RT)-related late effects are still a significant issue, particularly for younger pat
Externí odkaz:
https://doaj.org/article/42e4ac515a924546a3539aa769fb27ac
Autor:
Cristina Mantovani, Alessio Gastino, Marzia Cerrato, Serena Badellino, Umberto Ricardi, Mario Levis
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Brain metastases (BMs) represent the most frequent event during the course of Non-Small Cell Lung Cancer (NSCLC) disease. Recent advancements in the diagnostic and therapeutic procedures result in increased incidence and earlier diagnosis of BMs, wit
Externí odkaz:
https://doaj.org/article/6e2f079827f34507859f91384bf7775b
Autor:
Elisa Lucchini, Chiara Rusconi, Mario Levis, Francesca Ricci, Armando Santoro, Umberto Ricardi, Stefano Volpetti, Fabio Matrone, Anna Di Russo, Manuela Caizzi, Anna Schiattarella, Francesco Zaja
Publikováno v:
Hematology Reports, Vol 13, Iss 2 (2021)
The rate of complete remission (CR) with the anti-PD1 immune checkpoint inhibitors (ICI) nivolumab (N) and pembrolizumab (P) in patients with relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) is low (20-30%), and the majority of patients eve
Externí odkaz:
https://doaj.org/article/35964a569f1b49e1b155084f149ad497
Autor:
Elena Gallio, Anna Sardo, Serena Badellino, Cristina Mantovani, Mario Levis, Christian Fiandra, Alessia Guarneri, Francesca Arcadipane, Veronica Richetto, Umberto Ricardi, Francesca Romana Giglioli
Publikováno v:
Radiological Physics and Technology. 16:272-283
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9b71a1122940d705c936ed943f8e7b
https://doi.org/10.1007/s12194-023-00716-3
https://doi.org/10.1007/s12194-023-00716-3
Autor:
Maja V Maraldo, Mario Levis, Alessandro Andreis, Saro Armenian, James Bates, Jessica Brady, Alessandra Ghigo, Alexander R Lyon, Charlotte Manisty, Umberto Ricardi, Marianne C Aznar, Andrea Riccardo Filippi
Publikováno v:
The Lancet Haematology. 9:e445-e454
In potentially curable cancers, long-term survival depends not only on the successful treatment of the malignancy but also on the risks associated with treatment-related toxicity, especially cardiotoxicity. Malignant lymphomas affect patients at any
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0455a981c27a08cd9edcd759b6f96d
https://doi.org/10.1016/s2352-3026(22)00082-5
https://doi.org/10.1016/s2352-3026(22)00082-5